Dr. Bassam Damaj Appointed to Hispanica International Delights of America, Inc. Board of Directors
Hispanica International Delights of America, Inc. (OTC:HISP), a diversified food and beverage company in the Hispanic and ethnic food industry, announced today the appointment of Bassam Damaj, PhD to its Board of Directors. Dr. Damaj brings with him the expertise of navigating the public markets. He currently serves as President & CEO of Innovus Pharma (OTCQB:INNV). Prior to joining Innovus, Dr. Damaj served as President & Chief Executive Officer of Apricus Biosciences, Inc., from December 2009 until November 2012. At...
View full press release